Clinical Trial

Efficacy of Intravenous Oxytocin to Speed Recovery After THA

Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to test whether perioperative intravenous (IV) oxytocin compared to placebo results in faster recovery in disability as measured by daily steps over 56 days after Total Hip Arthroplasty (THA).
Protocol Amendment History 5 changes
critical Trial status changed: Not Yet Recruiting → Enrolling by Invitation 2026-05-28
notable Primary completion pushed: 2027-06 -> 2027-12 2026-05-28
minor Completion pushed: 2027-06 -> 2027-12 2026-05-28
notable Primary completion pushed: 2027-05 -> 2027-06 2026-03-31
minor Completion pushed: 2027-05 -> 2027-06 2026-03-31
Trial Details
NCT Number NCT07430228
Lead Sponsor Wake Forest University Health Sciences
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions Total Hip Arthroplasty
Enrollment 80 participants
Start Date 2026-08
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-28